3914 news items
Page 9 of 100
qglgr9af8vkubdem7cbflz h57a16lcfuu0mp89j7cdrsumkxxch9j64i
RBT
20 May 24
) Rubicon's execution of anticipated operational efficiency initiatives, cost reduction measures and financing arrangements; and 6) other risks
8lih9o01xsg2qtrn2lvs1zga51pqml2samm0qajfq379hsrfy0v8i85y4l
KEYS
20 May 24
detailed in Keysight's filings with the Securities and Exchange Commission on Keysight's yearly report on Form 10-K for the period ended October 31
lemmamg0rst
REGN
20 May 24
. INDICATIONS DUPIXENT is a prescription medicine used: to treat adults and children 6 months of age
6yqdbdqj2m7m1ogj248tro3moqpsoz6ypu5o 7k4ikez6
REGN
20 May 24
@sanofi.comVictor Rouault | + 33 6 70 93 71 40
twefxtdg85 i82t
20 May 24
has helped more than 9,200 adults graduate through similar programs in nine other states. The results of a survey taken 6-9 months after graduation
vsf9tf1b
20 May 24
vertically integrated STEM curricula throughout K-12. Establish stackable STEM credentials, leading to industry-recognized CTE certificates and STEM
wugm46xjkz9r1qzb04nea 1j3v3tx0jzmiz7ibcsi4k
OLB
20 May 24
, announced today that it has received a written letter from Nasdaq, which has determined that for the last 10 consecutive business days, from May 6, 2024
3cpg4op1y6fauxfm8f9o3wdn2eqit54jbiy6
HIMS
20 May 24
in the "Risk Factors" section of each of our most recently filed Quarterly Report on Form 10-Q, our most recently filed Annual Report on Form 10-K, and any
hfjk6f58gh tqfbabxiw4yvo0la7cfw
GRI
20 May 24
products, and any related restrictions and limitations of any cleared or approved product; (6) the inability of the Company to identify, in-license
f6zdp0tdlco2n7276bedfwhcmbunxqwt7fdsm1z290qb99gn0kchl
NCLH
20 May 24
recently filed Annual Report on Form 10-K and subsequent filings with the Securities and Exchange Commission. The above examples are not exhaustive
5yo1vq8u8qj iov4b
OI
20 May 24
consolidation of the Company's customer base, (6) the Company's ability to improve its glass melting technology, known as the modular advanced glass
jr5vrxlc673y4e2x6t5vr13n1mh1tgqr0i6xzgbdekodzdl6b2l09me
JCI
20 May 24
to be June 6, 2024, the third business day after the Early Tender Date. Securities validly tendered at or prior to the Early Tender Date
5yn0x pelmtmdm
STRR
20 May 24
report on Form 8-K filed with the Securities and Exchange Commission on May 20, 2024. About Star Equity Holdings, Inc
qxrsdtumqe38f7ahilb85i7700vs64cyyuibrd
BEAT
20 May 24
% for HeartBeam AI+VCG vs. 69.4% for EP panel).
Demonstrated a statistically significant 6% improvement
j918bvdmm f6kc
EOLS
20 May 24
dermal filler, Evolysse™ Lift, met primary endpoint of non-inferiority and demonstrated superiority to Restylane-L at 6 months; Secondary
e4bbx1b3
BAER
20 May 24
) Bridger's exploration of, need for, or completion of any future financings, and (6) anticipated investments in additional aircraft, capital resources
xeerr3uv8cocdtxc22rds0naotzt97y9t3zu8lp1ph8u4 y6a5wc8j5prc
20 May 24
factors can be found in Johnson & Johnson's Annual Report on Form 10-K for the fiscal year ended
zyflkhrtl7i2cbtuy0fton4jndyoqmk9pi35vom8cifgh7bfc31w 8ii6
20 May 24
of patients with sustained persistent AF lasting 6 months or longer prior to enrollment. Patients in the Tailored cohort experienced a higher rate
2sfu5lrr5xf1bft20qzbhlx1izqu7kvp5k2wiqt0sxde8d2pmhm8kvo hx3
AIXI
20 May 24
as its current reports on Form 6-K and other filings, all of which are available for review
4opbvdjdc4ywmhm0qq4xayn5nr9zv5knqqjv8i879r
MESA
20 May 24
filings with the SEC, including the risk factors contained in its most recent Annual Report on Form 10-K and the Company's other subsequent filings